A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients
Open Access
- 8 November 2019
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Cancer
- Vol. 19 (1), 1-12
- https://doi.org/10.1186/s12885-019-6288-7
Abstract
To reveal roles of reactive oxygen species (ROS) status in chemotherapy resistance and to develop a ROS scoring system for prognosis prediction in ovarian cancer. We tested the sensitizing effects of ROS elevating drugs to cisplatin (cDDP) in ovarian cancer both in vitro and in vivo. A ROS scoring system was developed using The Cancer Genome Atlas (TCGA) database of ovarian cancer. The associations between ROS scores and overall survival (OS) were analyzed in TCGA, Tothill dataset, and our in-house dataset (TJ dataset). ROS-inducing drugs increased cisplatin-induced ovarian cancer cell injury in vitro and in vivo. ROS scoring system was established using 25 ROS-related genes. Patients were divided into low (scores 0–12) and high (scores 13–25) score groups. Improved patient survival was associated with higher scores (TCGA dataset hazard ratio (HR) = 0.43, P < 0.001; Tothill dataset HR = 0.65, P = 0.022; TJ dataset HR = 0.40, P = 0.003). The score was also significantly associated with OS in multiple datasets (TCGA dataset r2 = 0.574, P = 0.032; Thothill dataset r2 = 0.266, P = 0.049; TJ dataset r2 = 0.632, P = 0.001) and with cisplatin sensitivity in ovarian cancer cell lines (r2 = 0.799, P = 0.016) when used as a continuous variable. The scoring system showed better prognostic performance than other clinical factors by receiver operating characteristic (ROC) curves (TCGA dataset area under the curve (AUC) = 0.71 v.s. 0.65, Tothill dataset AUC = 0.73 v.s. 0.67, TJ dataset AUC = 0.74 v.s. 0.66). ROS status is associated with chemotherapy resistance. ROS score system might be a prognostic biomarker in predicting the survival benefit from ovarian cancer patients.Keywords
Funding Information
- National Key Scientific Instrument and Equipment Development Projects of China (2016YFC1303012)
- National Basic Research Program of China (2015CB553903)
- National Science-technology Supporting Plan Projects (2015BAI13B05)
- Chinese National Key Plan of Precision Medicine Research (2016YFC0902901)
- Nature and Science Foundation of China (81402163, 81402164, 81472783, 81572569, 81501530, 81671394, 81370469)
- International S&T Cooperation Program of China (2013DFA31400)
- Research Project of Health and Family Planning Commission of Hubei Province (WJ2015MA001)
This publication has 35 references indexed in Scilit:
- Reactive Oxygen Species in Normal and Tumor Stem CellsAdvances in Cancer Research, 2014
- A longitudinal analysis with CA-125 to predict overall survival in patients with ovarian cancerJournal of Gynecologic Oncology, 2014
- Metabolic Regulation by p53 Family MembersCell Metabolism, 2013
- Oxidative stress and cancer: An overviewAgeing Research Reviews, 2013
- Integrated genomic analyses of ovarian carcinomaNature, 2011
- Individual responses to chemotherapy-induced oxidative stressBreast Cancer Research and Treatment, 2010
- Reactive oxygen species in cancerFree Radical Research, 2010
- Chemotherapy-Associated Oxidative Stress: Impact on Chemotherapeutic EffectivenessIntegrative Cancer Therapies, 2004
- Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cellsGene, 2004
- A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumorsCancer, 2003